What Is Cell and Gene Therapy?

Cell and Gene Therapy, commonly referred to as CGT, represents a transformative class of medical treatments. Cell therapy involves transferring living cells with a specific function into a patient’s body to treat or potentially cure a disease. Gene therapy involves introducing, removing, or changing genetic material within a patient’s cells to correct an underlying genetic defect.

CGT products include autologous cell therapies, in which each batch is manufactured exclusively for a single patient; allogeneic cell therapies derived from healthy donors; viral vectors used for in vivo gene delivery; and genetically modified cell products, such as CAR T cells. Unlike traditional small-molecule drugs that are chemically synthesized and can be terminally sterilized, CGT products are often living, patient-specific, and cannot be terminally sterilized without destroying the therapeutic agent. This fundamental difference places extraordinary demands on aseptic processing, environmental monitoring, and regulatory compliance.

Why CGT Manufacturing Requires Specialized GxP Training

Manufacturing a cell or gene therapy product is vastly more complex than producing a traditional pharmaceutical. The starting material comes directly from a patient or donor and is inherently variable. No two donors are identical. The manufacturing process itself directly influences cell behavior, and a single batch may contain millions of individual cells with varying characteristics. Quality control approaches that work well for chemically defined substances are often insufficient for living cell products.

Regulatory authorities, including the FDA, EMA, and Health Canada, all require rigorous controls. These include donor screening and testing, cell banking systems, viral vector manufacturing controls, adventitious agent safety evaluation, and extensive quality testing for sterility, mycoplasma, potency, viability, and replication-competent virus. Facilities must be designed with Class 100 or ISO 5 cleanrooms at points of exposure, validated HVAC systems, continuous environmental monitoring, and robust cold chain infrastructure.

Without comprehensive, role-based training, your organization faces significant risks. Clinical holds due to insufficient Chemistry, Manufacturing, and Controls information. Manufacturing deviations that compromise product quality. Regulatory rejections that delay or block market access. Patient safety events that could have been prevented.

How GxP Trainings Solve Your CGT Compliance Challenges

At GxP Trainings, we provide accredited, 21 CFR Part 11-compliant certification programs specifically designed for the Cell and Gene Therapy industry. Our training covers the complete manufacturing workflow from raw material sourcing to final product release, including donor eligibility determination, cell isolation and expansion, genetic modification using viral and non-viral methods, purification and formulation, cryopreservation and storage, and transportation logistics for temperature-sensitive products.

Our Cell and Gene Therapy Manufacturing Excellence program equips your team to interpret and apply global regulatory requirements with strategic foresight, design Chemistry, Manufacturing, and Controls strategies that satisfy multiple jurisdictional expectations simultaneously, evaluate manufacturing changes and execute comparability assessments that withstand regulatory scrutiny, mitigate risks associated with human and animal-derived materials, and lead organizational compliance efforts for both investigational and commercial CGT products.

➡️ Explore the full CGT training catalog at GxP Trainings and equip your team with the knowledge to pass any regulatory inspection.
Cell and Gene Therapy Manufacturing I CGT Training I GxP

Beyond CGT: Complete GxP Training for the Entire Life Sciences Industry.

While CGT manufacturing demands specialized knowledge, your organization also needs ongoing excellence across all applicable GxP standards. GxP Trainings offers a comprehensive library covering Good Manufacturing Practice, Good Clinical Practice, Good Laboratory Practice, Quality Assurance, Regulatory Affairs, Pharmacovigilance, and Medical Devices. All courses are designed by industry experts, updated to reflect current regulatory guidance, and delivered through an easy-to-use online platform that tracks and documents every certification.

Whether you are a Regulatory Affairs Director overseeing a global gene therapy program, a Quality Assurance Executive managing multiple manufacturing sites, a Compliance Officer specializing in biologics, or a Manufacturing Operations Leader establishing a new CGT production facility, GxP Trainings has the exact certification you need.

Take the Next Step Toward CGT Manufacturing Excellence

Do not let regulatory complexity delay your therapy from reaching patients. Ensure your team is fully prepared for inspections, regulatory submissions, and commercial-scale production. Visit GxP Trainings today to explore our Cell and Gene Therapy training pathway and all our life sciences GxP certification programs. Your patients are counting on you. Your regulators are watching. And we are here to help you succeed.ngs today to explore our Cell and Gene Therapy training pathway and all our life sciences GxP certification programs. Your patients are counting on you. Your regulators are watching. And we are here to help you succeed.